Oncotarget Podcast Episodes Online

Loading podcasts

Fetching podcast shows and categories...

Loading page

Opening Radio and Podcast...

Ready2SERAustralia · College Radio, World Music

Live--:--

Oncotarget Podcast Episodes Online | Radio and Podcast

Episodes

50 of 500 episodes

Targeted Therapies Drive Long-Term Decline in Multiple Myeloma Mortality in the U.S.

BUFFALO, NY – April 29, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on April 28, 2026, titled “Targeted therapeut...

00:03:23Apr 29, 2026

SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing

Cancer has long been understood through a variety of biological frameworks, including genetic mutations, dysregulated signaling pathways, an...

00:05:40Apr 21, 2026

Epigenetic Dysregulation of PDX1 Drives Prostate Cancer Progression

BUFFALO, NY – April 15, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Epigenetic dysregu...

00:02:40Apr 15, 2026

Cancer Care in Conflict Zones Remains Critically Neglected

BUFFALO, NY – April 13, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Cancer without borders: Po...

00:02:04Apr 13, 2026

Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency

BUFFALO, NY – April 10, 2026 – A new #editorial perspective was #published in Volume 17 of Oncotarget on April 8, 2026, titled “Oncotarget:...

00:01:57Apr 10, 2026

CREB5: A Master Regulator of Stem Cell-Like Programs in Prostate Cancer Progression

Androgen receptor (AR) signaling has long been the central driver of prostate cancer progression and the primary target of therapies for adv...

00:10:49Apr 7, 2026

Adjuvant PD-1/PD-L1 Inhibitors Show Efficacy but Highlight Safety Considerations in Solid Cancers

BUFFALO, NY – April 7, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Efficacy and safety...

00:02:49Apr 7, 2026

Bibliometric Mapping Reveals the Evolution of Glioma Classification Research

BUFFALO, NY – April 6, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Bibliometric mapping of gli...

00:02:28Apr 6, 2026

The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells

BUFFALO, NY – March 31, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 27, 2026, titled “The SCD1 inhibitor...

00:02:12Mar 31, 2026

Predicting Colorectal Cancer Survival: How Machine Learning Combines Clinical and Biological Clues

Colorectal cancer (CRC) ranks among the most common and lethal cancers worldwide, accounting for approximately 10% of all cancer diagnoses....

00:08:36Mar 25, 2026

CREB5 Linked to Stem Cell-Like Programs That Promote Prostate Cancer Progression

BUFFALO, NY – March 24, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 17, 2026, titled “CREB5 regulates st...

00:02:52Mar 24, 2026

Impact Journals to Participate at AACR Annual Meeting 2026 in San Diego

BUFFALO, NY – March 16, 2026 – Impact Journals (publisher of Aging-US, Oncotarget, Oncoscience, and Genes & Cancer), is pleased to announce...

00:01:40Mar 16, 2026

CAR-T Cell Therapy: A Revolutionary Approach to Cancer Treatment

Cancer treatment has long been a battle of attrition—surgery, radiation, and chemotherapy have saved countless lives, but for patients with...

00:06:44Mar 10, 2026

mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review

The rapid development and global deployment of mRNA vaccines for COVID-19 represented a landmark achievement in public health. However, the...

00:08:38Feb 27, 2026

Next-Generation CAR-T Designs That Could Transform Cancer Treatment

BUFFALO, NY – February 25, 2026 – A new #editorial perspective was #published in Volume 17 of Oncotarget on February 20, 2026, titled “CAR-T...

00:02:49Feb 25, 2026

Researchers Question Editorial Bias in COVID-19 Vaccine Debate

BUFFALO, NY – February 16, 2026 – A new #commentary was #published in Volume 17 of Oncotarget on February 6, 2026, titled “Censorship in sci...

00:03:56Feb 16, 2026

Case Report Explores Potential Link Between mRNA COVID-19 Vaccines and Cancer

BUFFALO, NY – February 11, 2026 – A new #casereport was published in Volume 17 of Oncotarget on February 6, 2026, titled “Exploring the pote...

00:03:54Feb 11, 2026

How HPV and COVID-19 Spike Proteins May Interact to Impact Cancer Suppression

The p53 protein plays a central role in preventing cancer by responding to cellular stress and DNA damage. When activated, it can repair dam...

00:04:02Feb 9, 2026

Exploring Possible Links Between COVID-19 Vaccination, Infection, and Cancer

A growing number of post-pandemic reports have described cancer diagnoses, recurrence, or progression following COVID-19 vaccination or SARS...

00:06:49Jan 26, 2026

Overcoming Aromatase Inhibitor Resistance in Breast Cancer: A New Therapeutic Strategy

Most breast cancers depend on estrogen to grow. This dependence explains why hormone-based treatments, such as aromatase inhibitors, are amo...

00:05:44Jan 13, 2026

New Hypothesis Links HPV E6 and SARS‑CoV‑2 Spike Proteins to Reduced p53 Activity

BUFFALO, NY – January 13, 2026 – A new #hypothesis article was #published in Oncotarget (Volume 17) on January 3, 2026, titled “Hypothesis:...

00:03:09Jan 13, 2026

Evaluation of Cancer Reports Following COVID-19 Vaccination and Infection

BUFFALO, NY – January 8, 2026 – A new #review was #published in Oncotarget (Volume 17) on January 3, 2026, titled “COVID vaccination and pos...

00:03:35Jan 8, 2026

Colorectal Cancer Survival Predicted by AI Using Clinical and Molecular Features

BUFFALO, NY - December 17, 2025 – A new #research paper was #published in Oncotarget (Volume 16) on December 15, 2025, titled “Machine learn...

00:03:23Dec 17, 2025

Comprehensive Genomic Profiling in Cancer: Insights from Over 10,000 Tumors

Cancer treatment is moving toward a more precision-based approach, where therapies are guided not just by the tumor’s location but also by i...

00:05:14Dec 15, 2025

Repurposing Statins: Exploring Anti-Tumor Effects in Colorectal Cancer

Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths globally. While early detection significantly improves out...

00:05:06Dec 3, 2025

New Antibody Removes Tregs to Boost Immune Response Against Cancer

Cancer is a disease caused by the uncontrolled growth of cells that escape the body’s natural defenses. One way cancer protects itself is by...

00:04:31Nov 19, 2025

Probiotic Bifidobacterium May Boost Cancer Treatment and Suppress Tumors

BUFFALO, NY – November 18, 2025 – A new #review was #published in Oncotarget (Volume 16) on November 14, 2025, titled “Mechanism of anticanc...

00:03:29Nov 18, 2025

Clinical Trial Participants Call for More Inclusive, Patient-Centered Cancer Research

BUFFALO, NY – November 17, 2025 – A new #research perspective was #published in Oncotarget (Volume 16) on November 14, 2025, titled “A perso...

00:03:44Nov 17, 2025

Lower LRIG1 Expression Linked to Aggressive Gliomas

BUFFALO, NY - November 12, 2025 – A new #research paper was #published in Oncotarget (Volume 16) on November 6, 2025, titled “LRIG1-3 in gli...

00:03:45Nov 12, 2025

Eco-Friendly Nanoparticles Improve Cidofovir’s Anticancer and Antiviral Effects

BUFFALO, NY - November 10, 2025 – A new #research paper was #published in Oncotarget (Volume 16) on November 6, 2025, titled “Anti-DNA virus...

00:04:05Nov 10, 2025

How Low Oxygen Shields Prostate Cancer from Ferroptosis Therapies

Prostate cancer is one of the most common cancers in men. While treatment options have improved, advanced stages of the disease remain diffi...

00:03:49Nov 6, 2025

Genetic Study Identifies Potential Diagnostic Marker for Rare Blood Cancer BPDCN

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare blood cancer that primarily affects older adults. One of the key challenges i...

00:03:50Oct 22, 2025

Folate Receptor Beta Found in Pediatric Tumors May Improve Fluorescence-Guided Cancer Surgery

BUFFALO, NY – October 20, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on October 16, 2025, titled “Widespread fol...

00:03:33Oct 20, 2025

New Radiofrequency Therapy Slows Glioblastoma Growth and Targets Tumor Stem Cells

BUFFALO, NY – October 14, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on October 13, 2025, titled “Treatment of g...

00:02:43Oct 14, 2025

New Insights into HER2-Mutated Non-Small Cell Lung Cancer in Brazil

Lung cancer remains one of the leading causes of cancer-related deaths worldwide. Although precision medicine has improved outcomes for many...

00:05:01Oct 8, 2025

Engineered Bacterial Therapy Activates Immune Response in Cancer Preclinical Studies

BUFFALO, NY – October 8, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on October 6, 2025, titled “ACTM-838, a nove...

00:03:57Oct 8, 2025

Wafik S. El-Deiry Chairs 2025 WIN Symposium in Collaboration with APM in Philadelphia

BUFFALO, NY - October 1, 2025 – Oncotarget is proud to announce that its Editor-in-Chief, Wafik S. El-Deiry, MD, PhD, FACP, will chair the W...

00:03:50Oct 1, 2025

Precision Oncology in Metastatic Colorectal Cancer: A Real-World Case Study

Colorectal cancer is one of the most common—and deadliest—cancers worldwide. Once it spreads and reaches the metastatic stage, treatment bec...

00:04:41Sep 24, 2025

Loss of Trp53 Gene Promotes Tumor Growth and Immune Suppression in Ovarian Cancer

BUFFALO, NY - September 24, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on September 22, 2025, titled “Loss of Tr...

00:03:24Sep 24, 2025

Immunotherapy Response in Pancreatic Cancer: What a New Study Reveals

Immunotherapy is not usually effective against pancreatic cancer (PC), but a new study published in Oncotarget (Volume 16, 2025) highlights...

00:04:59Sep 11, 2025

Blocking Protein Control Pathway Slows Rhabdomyosarcoma Growth in Mice

BUFFALO, NY – August 29, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on August 29, 2025, titled “In vivo manipula...

00:03:58Aug 29, 2025

Behind the Study: R-spondin Family Roles in Metastatic Prostate Cancer

Aiden Deacon from the University of Minnesota-Twin Cities, Minneapolis, discusses a research paper he co-authored that was published in Volu...

00:07:06Aug 26, 2025

Amivantamab Monotherapy in Rare EGFR-Mutated Advanced NSCLC

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality. While the development of targeted therapies has impr...

00:05:27Aug 26, 2025

Aramchol Boosts Regorafenib Effectiveness in Gastrointestinal Tumors

BUFFALO, NY – August 19, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on August 19, 2025, titled “The SCD1 inhibit...

00:03:35Aug 19, 2025

FDA-Approved MI Cancer Seek Test Enhances Tumor Profiling for Precision Oncology

BUFFALO, NY – August 15, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on August 13, 2025, titled “Clinical and ana...

00:04:13Aug 15, 2025

New Compound Disrupts Survival Pathways in Aromatase Inhibitor-Resistant Breast Cancer Cells

BUFFALO, NY - August 13, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on July 29, 2025, titled “PCAIs stimulate MA...

00:03:57Aug 12, 2025

Cigarette Smoke and Weak DNA Repair: A Double Hit Behind Lung Cancer Risk

Lung cancer, particularly non-small cell lung cancer (NSCLC), is the deadliest cancer worldwide. Cigarette smoking is one of the main causes...

00:05:37Aug 11, 2025

New Gene Linked to Aggressive, Treatment-Resistant Prostate Cancer

BUFFALO, NY – August 11, 2025 – A new #researchpaper was #published in Volume 16 of Oncotarget on July 25, 2025, titled “Dissecting the func...

00:03:35Aug 11, 2025

A New Way to Target Resistant Prostate Cancer Cells

Prostate cancer is the second most diagnosed cancer among men worldwide and remains a leading cause of cancer-related death. While early for...

00:05:14Jul 29, 2025

Comprehensive Genomic Testing Reveals Treatment Targets in 90% of Advanced Solid Tumors

BUFFALO, NY - July 29, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on July 25, 2025, titled “Comprehensive genomi...

00:03:32Jul 29, 2025